Q2 Earnings Estimate for Danaher Issued By Leerink Partnrs

Danaher Co. (NYSE:DHR) – Leerink Partnrs reduced their Q2 2025 earnings per share (EPS) estimates for shares of Danaher in a note issued to investors on Wednesday, January 29th. Leerink Partnrs analyst P. Souda now anticipates that the conglomerate will post earnings of $1.74 per share for the quarter, down from their previous forecast of $1.88. The consensus estimate for Danaher’s current full-year earnings is $8.15 per share. Leerink Partnrs also issued estimates for Danaher’s Q3 2025 earnings at $1.85 EPS.

Danaher (NYSE:DHR) last issued its earnings results on Wednesday, January 29th. The conglomerate reported $2.14 earnings per share (EPS) for the quarter, meeting the consensus estimate of $2.14. Danaher had a net margin of 16.33% and a return on equity of 10.72%. During the same period last year, the firm posted $2.09 EPS.

A number of other research firms have also recently issued reports on DHR. UBS Group lowered their target price on Danaher from $309.00 to $305.00 and set a “buy” rating for the company in a report on Wednesday, October 23rd. Wells Fargo & Company decreased their price target on shares of Danaher from $280.00 to $240.00 and set an “equal weight” rating for the company in a research note on Thursday. Stifel Nicolaus raised their target price on shares of Danaher from $250.00 to $265.00 and gave the company a “hold” rating in a research report on Wednesday, October 23rd. Stephens reissued an “overweight” rating and set a $315.00 price target on shares of Danaher in a research report on Wednesday, October 23rd. Finally, Scotiabank initiated coverage on Danaher in a report on Monday, December 23rd. They issued a “sector perform” rating and a $265.00 price objective for the company. Six investment analysts have rated the stock with a hold rating and sixteen have assigned a buy rating to the company’s stock. According to data from MarketBeat.com, the stock currently has a consensus rating of “Moderate Buy” and a consensus target price of $278.00.

Danaher Price Performance

DHR opened at $222.56 on Friday. The company has a quick ratio of 1.01, a current ratio of 1.37 and a debt-to-equity ratio of 0.32. The company has a fifty day simple moving average of $235.66 and a 200 day simple moving average of $253.24. Danaher has a 12 month low of $221.34 and a 12 month high of $281.70. The stock has a market cap of $160.75 billion, a P/E ratio of 42.15, a P/E/G ratio of 4.22 and a beta of 0.83.

Institutional Trading of Danaher

Several hedge funds have recently bought and sold shares of the business. Wedge Capital Management L L P NC boosted its position in shares of Danaher by 3.2% during the third quarter. Wedge Capital Management L L P NC now owns 1,231 shares of the conglomerate’s stock valued at $342,000 after buying an additional 38 shares during the period. Meridian Financial Partners LLC grew its stake in Danaher by 4.4% in the 3rd quarter. Meridian Financial Partners LLC now owns 957 shares of the conglomerate’s stock worth $266,000 after acquiring an additional 40 shares in the last quarter. Kovack Advisors Inc. raised its stake in shares of Danaher by 3.4% during the third quarter. Kovack Advisors Inc. now owns 1,243 shares of the conglomerate’s stock valued at $346,000 after acquiring an additional 41 shares in the last quarter. Well Done LLC boosted its holdings in shares of Danaher by 1.2% in the third quarter. Well Done LLC now owns 3,551 shares of the conglomerate’s stock valued at $987,000 after purchasing an additional 42 shares during the period. Finally, Waypoint Capital Advisors LLC increased its holdings in Danaher by 0.9% during the 3rd quarter. Waypoint Capital Advisors LLC now owns 4,520 shares of the conglomerate’s stock worth $1,257,000 after purchasing an additional 42 shares during the period. Institutional investors and hedge funds own 79.05% of the company’s stock.

Insider Transactions at Danaher

In related news, SVP Brian W. Ellis sold 5,700 shares of the stock in a transaction on Thursday, January 30th. The shares were sold at an average price of $224.13, for a total transaction of $1,277,541.00. Following the transaction, the senior vice president now directly owns 20,230 shares of the company’s stock, valued at $4,534,149.90. This represents a 21.98 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through the SEC website. 11.10% of the stock is currently owned by corporate insiders.

Danaher Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Friday, January 31st. Stockholders of record on Friday, December 27th were given a dividend of $0.27 per share. The ex-dividend date was Friday, December 27th. This represents a $1.08 dividend on an annualized basis and a dividend yield of 0.49%. Danaher’s dividend payout ratio (DPR) is 20.45%.

About Danaher

Danaher Corporation designs, manufactures, and markets professional, medical, industrial, and commercial products and services worldwide. The Biotechnology segments offers bioprocess technologies, consumables, and services that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufacturing, chromatography resins, filtration technologies, aseptic fill finish; single-use hardware and consumables and services, such as the design and installation of full manufacturing suites; lab filtration, separation, and purification; lab-scale protein purification and analytical tools; reagents, membranes, and services; and healthcare filtration solutions.